INCY Incyte Corporation - Common Stock
$124,17
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 28, 2026
52W-Spanne
$81–$133
84% of range
Analystenbewertung
HOLD
33 analysts
Kursziel
$125
+1% upside
P/E (TTM)
19.4
ROE
27.6%
Nettogewinnmarge
25.0%
Über Incyte Corporation - Common Stock Unternehmensübersicht von Wikipedia
Incyte Inc. ist ein US-amerikanisches Pharmaunternehmen mit Sitz in Wilmington, Delaware. Das Unternehmen vertreibt das durch die U.S. Food and Drug Administration (FDA) geprüfte Medikament Jakavi (Handelsmarke) mit dem Wirkstoff Ruxolitinib, das mehreren Tausend Patienten in den Vereinigten Staaten verschrieben wurde.
Mehr lesen
Incyte Inc. ist ein US-amerikanisches Pharmaunternehmen mit Sitz in Wilmington, Delaware. Das Unternehmen vertreibt das durch die U.S. Food and Drug Administration (FDA) geprüfte Medikament Jakavi (Handelsmarke) mit dem Wirkstoff Ruxolitinib, das mehreren Tausend Patienten in den Vereinigten Staaten verschrieben wurde.
Im Jahr 2014 ernannte das Unternehmen Hervé Hoppenot zum Präsidenten und CEO. Hoppenot war zuvor Präsident der onkologischen Abteilung von Novartis und war dort seit 2003 angestellt. Er ging 2025 in den Ruhestand und wurde durch Bill Meury ersetzt.
2021 eröffnete Incyte das europäische Hauptquartier in Morges am Genfer See in der Schweiz.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
INCY Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$124.17
Marktkapitalisierung
$24.64B
P/E (TTM)
19.4
EPS (TTM)
$6.41
Umsatz (TTM)
$5.14B
Dividendenrendite
—
ROE
27.6%
Verschuldungsgrad
—
52W-Spanne
$81 – $133
INCY Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$5.14B
2016-12-31
→
2025-12-31
EPS
$6.41
2016-12-31
→
2025-12-31
Freier Cashflow
—
2017-12-31
→
2022-12-31
Margen
25.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
INCY
Peer-Median
P/E (TTM)
19.4
17.7
P/S (TTM) (K/V (TTM))
4.8
6.8
P/B (K/B)
4.8
6.4
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
INCY
Peer-Median
Operating Margin (Betriebsgewinnmarge)
29.5%
—
Net Profit Margin (Nettogewinnmarge)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
INCY
Peer-Median
Current Ratio (Liquiditätsgrad)
3.3
3.4
Quick Ratio
2.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
INCY
Peer-Median
Revenue YoY (Umsatz YoY)
21.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
14.8%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
14.0%
—
EPS YoY (EPS VjV)
4173.3%
—
Net Income YoY (Nettogewinn YoY)
3845.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
INCY
Peer-Median
INCY Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
33 Analysten
- Starker Kauf 8 24,2%
- Kauf 9 27,3%
- Halten 16 48,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
23 Analysten · 2026-08-18
Median
$120.00
Jetzt
$124.17
Tief
$86.00
Hoch
$155.00
Median-Ziel
$120.00
-3,4%
Mittelwert-Ziel
$125.17
+0,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.33%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $3.09 | $2.14 | 0.95% |
| 31. März 2026 | $1.81 | $1.40 | 0.41% |
| 31. Dezember 2025 | $1.80 | $1.97 | -0.17% |
| 30. September 2025 | $2.26 | $1.69 | 0.57% |
| 30. Juni 2025 | $1.57 | $1.50 | 0.07% |
| 31. März 2025 | $1.16 | $1.04 | 0.12% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
Wachstumsraten 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Betriebsgewinnmarge % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| Nettoergebnis | $1.29B | $33M | $598M | $341M | $949M |
| Verwässerte EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.3 | 2.0 | — | 3.5 | 3.7 |
| Quick Ratio | 2.0 | 1.0 | — | 2.6 | 2.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | — | — | $892M | $568M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 928 Einreicher · $16.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 129 (+10 vs. Vorquartal) | 66 (-31 vs. Vorquartal) | 345 (+31 vs. Vorquartal) | 261 (-21 vs. Vorquartal) | +18.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3.487.217.729 | 30.762.330 | 21,56% | Aktien |
| Dodge & Cox | $1.355.482.475 | 11.957.326 | 8,38% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.249.713.401 | 11.024.289 | 7,73% | Aktien |
| STATE STREET CORP | $1.102.124.009 | 9.722.336 | 6,81% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883.198.076 | 7.791.091 | 5,46% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $472.254.570 | 4.183.857 | 2,92% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $398.135.284 | 3.512.132 | 2,46% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $384.786.803 | 3.394.379 | 2,38% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311.168.439 | 2.744.958 | 1,92% | Aktien |
| Robeco Institutional Asset Management B.V. | $276.795.075 | 2.441.735 | 1,71% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $227.123.448 | 2.003.559 | 1,40% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $201.199.603 | 1.774.874 | 1,24% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191.845.249 | 1.692.354 | 1,19% | Aktien |
| FIRST TRUST ADVISORS LP | $180.015.041 | 1.587.996 | 1,11% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $167.811.569 | 1.480.342 | 1,04% | Aktien |
| Caisse de depot et placement du Quebec | $155.360.220 | 1.370.503 | 0,96% | Aktien |
| AustralianSuper Pty Ltd | $135.634.220 | 1.196.491 | 0,84% | Aktien |
| NORGES BANK | $126.861.970 | 1.119.107 | 0,78% | Aktien |
| FMR LLC | $116.316.542 | 1.026.081 | 0,72% | Aktien |
| ROYAL BANK OF CANADA | $115.263.000 | 1.016.790 | 0,71% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $106.959.694 | 943.540 | 0,66% | Aktien |
| ARMISTICE CAPITAL, LLC | $102.024.567 | 900.005 | 0,63% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $99.970.937 | 881.889 | 0,62% | Aktien |
| GOLDMAN SACHS GROUP INC | $97.568.045 | 860.692 | 0,60% | Aktien |
| VANGUARD GROUP INC | $91.396.622 | 925.348 | 0,56% | Aktien |
| Sound Shore Management Inc /CT/ | $85.895.479 | 757.723 | 0,53% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82.953.901 | 731.774 | 0,51% | Aktien |
| Gotham Asset Management, LLC | $81.567.621 | 719.545 | 0,50% | Aktien |
| Pictet Asset Management Holding SA | $81.315.880 | 713.354 | 0,50% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75.887.460 | 768.325 | 0,47% | Aktien |
| MACKENZIE FINANCIAL CORP | $71.967.956 | 634.862 | 0,44% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65.633.852 | 578.986 | 0,41% | Aktien |
| Legal & General Group Plc | $63.331.398 | 558.675 | 0,39% | Aktien |
| SEB Asset Management AB | $63.307.742 | 558.467 | 0,39% | Aktien |
| GLENMEDE TRUST CO NA | $60.308.653 | 532.010 | 0,37% | Aktien |
| Woodline Partners LP | $58.118.538 | 512.690 | 0,36% | Aktien |
| MARSHALL WACE, LLP | $56.804.130 | 501.095 | 0,35% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $56.779.870 | 500.881 | 0,35% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55.184.782 | 486.810 | 0,34% | Aktien |
| BlackRock, Inc. | $54.675.002 | 482.313 | 0,34% | Aktien |
| Swiss National Bank | $54.058.437 | 476.874 | 0,33% | Aktien |
| Glenmede Investment Management, LP | $53.145.338 | 626.640 | 0,33% | Aktien |
| Vinva Investment Management Ltd | $53.069.578 | 462.843 | 0,33% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $50.161.800 | 442.500 | 0,31% | Aktien |
| California Public Employees Retirement System | $48.730.290 | 429.872 | 0,30% | Aktien |
| RHUMBLINE ADVISERS | $48.578.406 | 428.533 | 0,30% | Aktien |
| IEQ CAPITAL, LLC | $48.141.997 | 424.682 | 0,30% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46.733.567 | 412.258 | 0,29% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $44.634.140 | 393.738 | 0,28% | Aktien |
| Vanguard Global Advisers, LLC | $43.080.994 | 380.037 | 0,27% | Aktien |
| MORGAN STANLEY | $42.894.746 | 378.394 | 0,27% | Aktien |
| Swedbank AB | $42.100.431 | 371.387 | 0,26% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $39.177.443 | 345.602 | 0,24% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38.530.157 | 339.892 | 0,24% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $38.125.008 | 336.318 | 0,24% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $37.984.782 | 335.081 | 0,23% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36.114.682 | 318.584 | 0,22% | Aktien |
| Aware Super Pty Ltd as trustee of Aware Super | $34.779.982 | 306.810 | 0,21% | Aktien |
| Arbejdsmarkedets Tillaegspension | $33.826.624 | 298.400 | 0,21% | Aktien |
| BARCLAYS PLC | $32.329.252 | 285.191 | 0,20% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32.129.398 | 283.428 | 0,20% | Aktien |
| Ensign Peak Advisors, Inc | $30.602.212 | 269.956 | 0,19% | Aktien |
| Illinois Municipal Retirement Fund | $29.511.916 | 260.338 | 0,18% | Aktien |
| WINTON GROUP Ltd | $28.839.691 | 254.408 | 0,18% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $28.624.373 | 252.509 | 0,18% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26.717.581 | 236.172 | 0,17% | Aktien |
| TODD ASSET MANAGEMENT LLC | $26.568.750 | 234.375 | 0,16% | Aktien |
| BANK OF AMERICA CORP /DE/ | $25.899.133 | 228.468 | 0,16% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $24.961.078 | 220.193 | 0,15% | Aktien |
| Andra AP-fonden | $24.381.598 | 259.048 | 0,15% | Aktien |
| Quantinno Capital Management LP | $24.309.704 | 214.446 | 0,15% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24.037.194 | 212.043 | 0,15% | Aktien |
| Baird Financial Group, Inc. | $23.690.539 | 208.985 | 0,15% | Aktien |
| Eurizon Capital SGR S.p.A. | $23.250.000 | 204.785 | 0,14% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22.709.932 | 241.287 | 0,14% | Aktien |
| Korea Investment CORP | $22.164.827 | 195.526 | 0,14% | Aktien |
| KLP KAPITALFORVALTNING AS | $21.799.695 | 192.305 | 0,13% | Aktien |
| Catalio Capital Management, LP | $21.722.837 | 191.627 | 0,13% | Aktien |
| PRUDENTIAL FINANCIAL INC | $21.650.853 | 190.992 | 0,13% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21.575.016 | 190.323 | 0,13% | Aktien |
| Fideuram Asset Management (Ireland) dac | $20.928.446 | 213.883 | 0,13% | Aktien |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20.401.285 | 179.969 | 0,13% | Aktien |
| APG Asset Management N.V. | $20.193.310 | 203.661 | 0,12% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19.499.734 | 172.016 | 0,12% | Aktien |
| SECTOR GAMMA AS | $19.356.560 | 170.753 | 0,12% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $19.137.209 | 168.818 | 0,12% | Aktien |
| CWM, LLC | $19.084.906 | 202.772 | 0,12% | Aktien |
| Bridgewater Associates, LP | $19.073.160 | 168.253 | 0,12% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $18.937.791 | 201.209 | 0,12% | Aktien |
| Candriam S.C.A. | $18.443.367 | 162.854 | 0,11% | Aktien |
| Focus Partners Wealth | $18.354.947 | 161.917 | 0,11% | Aktien |
| DNB Asset Management AS | $18.304.239 | 161.470 | 0,11% | Aktien |
| SEI INVESTMENTS CO | $18.019.140 | 158.955 | 0,11% | Aktien |
| Trails Edge Capital Partners, LP | $17.570.800 | 155.000 | 0,11% | Aktien |
| Jefferies Financial Group Inc. | $17.321.295 | 152.799 | 0,11% | Aktien |
| SAWGRASS ASSET MANAGEMENT LLC | $17.250.671 | 152.176 | 0,11% | Aktien |
| Mitsubishi UFJ Trust & Banking Corp | $17.215.756 | 151.868 | 0,11% | Aktien |
| AVIVA PLC | $16.882.025 | 148.924 | 0,10% | Aktien |
| Driehaus Capital Management LLC | $16.794.397 | 148.151 | 0,10% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $16.681.037 | 147.151 | 0,10% | Aktien |
Unternehmensinsider 61 Insider · 32 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 16. Juli 2026 A | 183.129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 15. Juli 2025 F | 517.146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 15. Juli 2025 A | 125.759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 16. Juli 2018 F | 10.235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 5. Juni 2014 M | 8.500 | 0 | 0 | $0 |
| Lee Heeson | EVP, Head of Incyte Intl | 23. Juli 2026 A | 32.778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 23. Juli 2026 A | 81.515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 16. Juli 2026 A | 16.861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 16. Juli 2026 A | 16.824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 16. Juli 2026 A | 11.497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16. Juli 2026 A | 71.797 | 0 | 1 | $-125.706 |
| Thomas Tray | Principal Accounting Officer | 16. Juli 2026 A | 21.699 | 0 | 1 | $-263.900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 16. Juli 2026 A | 30.916 | 0 | 2 | $-3.407.541 |
| Sheila A. Denton | EVP & General Counsel | 15. August 2025 M | 33.200 | 0 | 1 | $-24.046 |
| Vijay K Iyengar | EVP, GMAPPS | 16. Juli 2025 S | 40.540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 16. Juli 2025 S | 35.149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 15. Juli 2025 A | 15.016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 15. Juli 2025 A | 106.482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12. September 2024 S | 36.390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 14. Juli 2023 A | 58.968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 14. Juli 2023 A | 69.724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 19. Januar 2022 A | 32.268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2. Juli 2021 A | 98.575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 16. Juli 2018 F | 34.571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 13. September 2017 F | 21.053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 6. Januar 2016 M | 16.926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 23. Juni 2015 M | 3.521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 19. Januar 2012 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 10. Mai 2011 M | 4.500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 11. April 2011 M | 66.504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 18. Mai 2010 A | 38.137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 8. Februar 2008 A | — | 0 | 0 | $0 |
| Paul J Clancy | Direktor | 30. Juni 2026 A | 25.635 | 0 | 0 | $0 |
| Edmund Harrigan | Direktor | 30. Juni 2026 A | 23.019 | 0 | 0 | $0 |
| Katherine A High | Direktor | 8. Juni 2026 A | 14.983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Direktor | 8. Juni 2026 A | 20.968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | Direktor | 8. Juni 2026 A | 24.424 | 0 | 0 | $0 |
| Otis W Brawley | Direktor | 8. Juni 2026 A | 12.894 | 0 | 0 | $0 |
| Susanne Schaffert | Direktor | 12. Juni 2024 A | 5.720 | 0 | 0 | $0 |
| Wendy L Dixon | Direktor | 31. März 2022 A | 17.768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direktor | 26. Mai 2020 A | 256.813 | 0 | 0 | $0 |
| Paul A Brooke | Direktor | 31. März 2020 A | 221.911 | 0 | 0 | $0 |
| Barry A Ariko | Direktor | 12. März 2015 M | 45.834 | 0 | 0 | $0 |
| Richard U De Schutter | Direktor | 5. März 2015 M | 92.290 | 0 | 0 | $0 |
| Roy A Whitfield | Direktor | 17. Dezember 2013 M | 666.082 | 0 | 0 | $0 |
| John F Niblack | Direktor | 20. Mai 2011 A | — | 0 | 0 | $0 |
| Fred B Craves | Direktor | 1. Juni 2005 A | 196.793 | 0 | 0 | $0 |
| INCYTE CORP | 10%-Eigentümer | 25. Januar 2021 A | 3.550.000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | 10%-Eigentümer | 11. Februar 2004 S | — | 0 | 0 | $0 |
| Bonnie J Tisch | 10%-Eigentümer | 14. Januar 2004 S | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 Einreichungen | 11. Mai 2026 | 15,60% | Änderung | Passive Anlage | SEC |
| Incyte Corporation ×3 Einreichungen | 14. August 2023 | — | Erste Einreichung | Kapitalstruktur | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 Einreichungen | 15. Juni 2012 | — | Erste Einreichung | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 Einreichungen | 1. Oktober 2009 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 25. Februar 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 29. September 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 15. August 2002 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 214 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 4,05% | 67.570 SH | 8. August 2026 | Täglich |
| BRNY · EA Series Trust | 3,64% | 211.562 NS | 30. April 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2,97% | 89.311 SH | 8. August 2026 | Täglich |
| BUL · Pacer Funds Trust | 2,38% | 31.787 NS | 30. April 2026 | N-PORT |
| SAWG · ETF Series Solutions | 2,36% | 624 NS | 30. April 2026 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,32% | 23.365 SH | 8. August 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 201.047 NS | 30. April 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,98% | 623 NS | 30. April 2026 | N-PORT |
| SMRI · EA Series Trust | 1,96% | 111.283 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 1,81% | 1.453.479 SH | 8. August 2026 | Täglich |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,78% | 9.967 NS | 30. April 2026 | N-PORT |
| RPG · Invesco Exchange-Traded Fund Trust | 1,75% | 293.364 SH | 8. August 2026 | Täglich |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,75% | 337.040 SH | 8. August 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,73% | 112.472 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,64% | 10.873 SH | 8. August 2026 | Täglich |
| BBP · ETFis Series Trust I | 1,59% | 9.918 NS | 30. April 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,59% | 736 NS | 30. April 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1,55% | 561.166 NS | 30. April 2026 | N-PORT |
| NUMG · Nushares ETF Trust | 1,44% | 53.580 NS | 30. April 2026 | N-PORT |
| AGNG · Global X Funds | 1,36% | 11.515 NS | 31. Mai 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,21% | 275.493 NS | 30. April 2026 | N-PORT |
| FLOW · Global X Funds | 1,20% | 3.543 NS | 31. Mai 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,16% | 113.960 SH | 8. August 2026 | Täglich |
| GURU · Global X Funds | 1,01% | 6.203 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,97% | 7.359 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 51.287 NS | 30. April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,94% | 3.113 NS | 31. Mai 2026 | N-PORT |
| OASC · Unified Series Trust | 0,91% | 7.915 NS | 31. Mai 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,89% | 56.482 NS | 30. April 2026 | N-PORT |
| ROE · EA Series Trust | 0,87% | 23.347 NS | 29. Mai 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0,83% | 1.595 NS | 30. April 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,80% | 8.654 SH | 8. August 2026 | Täglich |
| JOET · Virtus ETF Trust II | 0,79% | 19.541 NS | 30. April 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,75% | 61.119 NS | 30. April 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,71% | 45.326 NS | 31. Mai 2026 | N-PORT |
| SDG · iShares Trust | 0,70% | 10.188 SH | 8. August 2026 | Täglich |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,64% | 85.796 NS | 30. April 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0,64% | 146.423 NS | 31. Mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,53% | 2.249.253 SH | 8. August 2026 | Täglich |
| EBI · RBB Fund Trust | 0,52% | 35.279 NS | 31. Mai 2026 | N-PORT |
| ESMV · iShares Trust | 0,51% | 339 SH | 8. August 2026 | Täglich |
| TECB · iShares Trust | 0,48% | 19.516 SH | 8. August 2026 | Täglich |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,48% | 7.994 NS | 31. Mai 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,46% | 19.147 SH | 8. August 2026 | Täglich |
| USMV · iShares Trust | 0,45% | 918.818 SH | 8. August 2026 | Täglich |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,45% | 29.860 NS | 31. Mai 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,44% | 4.411 NS | 31. Mai 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,44% | 832.413 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,43% | 2.130 NS | 30. April 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0,42% | 2.110 NS | 30. April 2026 | N-PORT |